Porte F, Granghaud A, Chang J, Kearney M, et al. Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France. PLoS One 2024;19:e0302548.
PMID: 38728337